BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 27547819)

  • 21. The Mycobacterium tuberculosis FAS-II dehydratases and methyltransferases define the specificity of the mycolic acid elongation complexes.
    Cantaloube S; Veyron-Churlet R; Haddache N; Daffé M; Zerbib D
    PLoS One; 2011; 6(12):e29564. PubMed ID: 22216317
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A polyketide synthase catalyzes the last condensation step of mycolic acid biosynthesis in mycobacteria and related organisms.
    Portevin D; De Sousa-D'Auria C; Houssin C; Grimaldi C; Chami M; Daffé M; Guilhot C
    Proc Natl Acad Sci U S A; 2004 Jan; 101(1):314-9. PubMed ID: 14695899
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HadBD dehydratase from Mycobacterium tuberculosis fatty acid synthase type II: A singular structure for a unique function.
    Bories P; Rima J; Tranier S; Marcoux J; Grimoire Y; Tomaszczyk M; Launay A; Fata K; Marrakchi H; Burlet-Schiltz O; Mourey L; Ducoux-Petit M; Bardou F; Bon C; Quémard A
    Protein Sci; 2024 Apr; 33(4):e4964. PubMed ID: 38501584
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biosynthesis of cell envelope-associated phenolic glycolipids in Mycobacterium marinum.
    Vergnolle O; Chavadi SS; Edupuganti UR; Mohandas P; Chan C; Zeng J; Kopylov M; Angelo NG; Warren JD; Soll CE; Quadri LE
    J Bacteriol; 2015 Mar; 197(6):1040-50. PubMed ID: 25561717
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular basis of the functional divergence of fatty acyl-AMP ligase biosynthetic enzymes of Mycobacterium tuberculosis.
    Goyal A; Verma P; Anandhakrishnan M; Gokhale RS; Sankaranarayanan R
    J Mol Biol; 2012 Feb; 416(2):221-38. PubMed ID: 22206988
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanistic and functional insights into fatty acid activation in Mycobacterium tuberculosis.
    Arora P; Goyal A; Natarajan VT; Rajakumara E; Verma P; Gupta R; Yousuf M; Trivedi OA; Mohanty D; Tyagi A; Sankaranarayanan R; Gokhale RS
    Nat Chem Biol; 2009 Mar; 5(3):166-73. PubMed ID: 19182784
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increasing the structural coverage of tuberculosis drug targets.
    Baugh L; Phan I; Begley DW; Clifton MC; Armour B; Dranow DM; Taylor BM; Muruthi MM; Abendroth J; Fairman JW; Fox D; Dieterich SH; Staker BL; Gardberg AS; Choi R; Hewitt SN; Napuli AJ; Myers J; Barrett LK; Zhang Y; Ferrell M; Mundt E; Thompkins K; Tran N; Lyons-Abbott S; Abramov A; Sekar A; Serbzhinskiy D; Lorimer D; Buchko GW; Stacy R; Stewart LJ; Edwards TE; Van Voorhis WC; Myler PJ
    Tuberculosis (Edinb); 2015 Mar; 95(2):142-8. PubMed ID: 25613812
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure and dynamics of the essential endogenous mycobacterial polyketide synthase Pks13.
    Kim SK; Dickinson MS; Finer-Moore J; Guan Z; Kaake RM; Echeverria I; Chen J; Pulido EH; Sali A; Krogan NJ; Rosenberg OS; Stroud RM
    bioRxiv; 2023 Jan; ():. PubMed ID: 36747776
    [No Abstract]   [Full Text] [Related]  

  • 30. Crystal structure of a substrate complex of Mycobacterium tuberculosis beta-ketoacyl-acyl carrier protein synthase III (FabH) with lauroyl-coenzyme A.
    Musayev F; Sachdeva S; Scarsdale JN; Reynolds KA; Wright HT
    J Mol Biol; 2005 Mar; 346(5):1313-21. PubMed ID: 15713483
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular modeling and docking studies of O-succinylbenzoate synthase of M. tuberculosis--a potential target for antituberculosis drug design.
    Pulaganti M; Banaganapalli B; Mulakayala C; Chitta SK; C M A
    Appl Biochem Biotechnol; 2014 Feb; 172(3):1407-32. PubMed ID: 24203275
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Crystal structure of MabA from Mycobacterium tuberculosis, a reductase involved in long-chain fatty acid biosynthesis.
    Cohen-Gonsaud M; Ducasse S; Hoh F; Zerbib D; Labesse G; Quemard A
    J Mol Biol; 2002 Jul; 320(2):249-61. PubMed ID: 12079383
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel interaction linking the FAS-II and phthiocerol dimycocerosate (PDIM) biosynthetic pathways.
    Kruh NA; Borgaro JG; Ruzsicska BP; Xu H; Tonge PJ
    J Biol Chem; 2008 Nov; 283(46):31719-25. PubMed ID: 18703500
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Crucial components of Mycobacterium type II fatty acid biosynthesis (Fas-II) and their inhibitors.
    Duan X; Xiang X; Xie J
    FEMS Microbiol Lett; 2014 Nov; 360(2):87-99. PubMed ID: 25227413
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The pathogenic mechanism of Mycobacterium tuberculosis: implication for new drug development.
    Yan W; Zheng Y; Dou C; Zhang G; Arnaout T; Cheng W
    Mol Biomed; 2022 Dec; 3(1):48. PubMed ID: 36547804
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure and inhibition of subunit I of the anthranilate synthase complex of Mycobacterium tuberculosis and expression of the active complex.
    Bashiri G; Johnston JM; Evans GL; Bulloch EM; Goldstone DC; Jirgis EN; Kleinboelting S; Castell A; Ramsay RJ; Manos-Turvey A; Payne RJ; Lott JS; Baker EN
    Acta Crystallogr D Biol Crystallogr; 2015 Nov; 71(Pt 11):2297-308. PubMed ID: 26527146
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutations in the essential FAS II β-hydroxyacyl ACP dehydratase complex confer resistance to thiacetazone in Mycobacterium tuberculosis and Mycobacterium kansasii.
    Belardinelli JM; Morbidoni HR
    Mol Microbiol; 2012 Nov; 86(3):568-79. PubMed ID: 22994892
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The missing piece of the type II fatty acid synthase system from Mycobacterium tuberculosis.
    Sacco E; Covarrubias AS; O'Hare HM; Carroll P; Eynard N; Jones TA; Parish T; Daffé M; Bäckbro K; Quémard A
    Proc Natl Acad Sci U S A; 2007 Sep; 104(37):14628-33. PubMed ID: 17804795
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative protein modeling of methionine S-adenosyltransferase (MAT) enzyme from Mycobacterium tuberculosis: a potential target for antituberculosis drug discovery.
    Khedkar SA; Malde AK; Coutinho EC
    J Mol Graph Model; 2005 Jan; 23(4):355-66. PubMed ID: 15670956
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identifying the Novel Inhibitors Against the Mycolic Acid Biosynthesis Pathway Target "mtFabH" of
    Kumar N; Srivastava R; Mongre RK; Mishra CB; Kumar A; Khatoon R; Banerjee A; Ashraf-Uz-Zaman M; Singh H; Lynn AM; Lee MS; Prakash A
    Front Microbiol; 2022; 13():818714. PubMed ID: 35602011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.